Loading
BT
Beijing Tong Ren Tang Chinese Medicine Co. Ltd. Stock: price and insider trades · Hong Kong
HK·Mcap HK$4.8B
No insider purchase over the last 90 days. The latest, by Chen Fei, was filed 27 Sept 2024.
Beijing Tong Ren Tang Chinese Medicine Co. Ltd.: what insiders have been doing
Every trade that managers of Beijing Tong Ren Tang Chinese Medicine Co. Ltd. disclose to HKEX is tracked on this page. Beijing Tong Ren Tang Chinese Medicine Co. Ltd. has had no insider filing for more than a year; the last one goes back to 27 September 2024.
The full history, which starts in 2018, counts 22 purchases against no sales.
For comparison within the same market, see the insider buying recorded at Sun Hung Kai Properties Ltd. and Xinyi Glass Holdings Ltd. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.
Insider Decl.
22
Thresholds
n/a
Buy Volume
€480,679
22 ops. · all time
Sell Volume
n/a
n/a
Since the insiders bought
- -4.1%Entry HK$9.21 · Close at T+365 HK$8.83
- +44.1%Entry HK$9.09 · Close at T+365 HK$13.10
- +44.1%Entry HK$9.09 · Close at T+365 HK$13.10
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 1,223 of 26,283 companies
79.4
score / 100
Value79
Quality79
FCF yld16%
Earn yld8.3%
EV/EBITDA8.1x
ROE8.8%
Gross mgn61%
Net mgn26%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
HK$5.75
Analyst consensus
2 analystsHK$9.00Target HK$9.75(+70%)HK$10.50
Income statement
RevenueHK$1.5B
Gross profitHK$925.6M61% margin
EBITDAHK$608.7M40% margin
Net incomeHK$397.2M26.6% margin
Valuation
PER (trailing)13.4x
PER (forward)9.7x
P/Book1.2x
Beta0.35
Balance sheet & cash
Market capHK$4.8B
Total debtHK$126.5M
Free Cash FlowHK$788.3M
Debt / Equity3%
Profitability & ownership
ROE8.8%
ROA5.9%
% insiders71.7%
% institutions2.9%
Last declaration on 27 September 2024
Declarations22 total
20,000 shares@ HK$9.0810.6% of flowShareXHKGHKEX:DA20220817E00072
Canonical exit: 15 Nov 2022 (T+90)
75,000 shares@ HK$8.3575.1% of flowShareXHKGHKEX:DA20200914E00011
Canonical exit: 10 Dec 2020 (T+90)
12,000 shares@ HK$8.215.0% of flowShareXHKGHKEX:DA20200911E00078
Canonical exit: 10 Dec 2020 (T+90)
25,000 shares@ HK$8.3124.9% of flowShareXHKGHKEX:DA20200911E00077
Canonical exit: 9 Dec 2020 (T+90)
30,000 shares@ HK$8.55213.1% of flowShareXHKGHKEX:DA20200908E00298
Canonical exit: 7 Dec 2020 (T+90)
18,000 shares@ HK$9.249.0% of flowShareXHKGHKEX:DA20200529E00330
Canonical exit: 26 Aug 2020 (T+90)
20,000 shares@ HK$10.4011.2% of flowShareXHKGHKEX:DA20191126E00055
Canonical exit: 20 Feb 2020 (T+90)
30,000 shares@ HK$12.43819.5% of flowShareXHKGHKEX:DA20181218E00209
Canonical exit: 18 Mar 2019 (T+90)
50,000 shares@ HK$12.979631.7% of flowShareXHKGHKEX:DA20180503E00258
Canonical exit: 26 Jul 2018 (T+90)
22 of 22 declarations
About Beijing Tong Ren Tang Chinese Medicine Co. Ltd.
Beijing Tong Ren Tang Chinese Medicine Co. Ltd. is a company engaged in the manufacturing and distribution of traditional Chinese medicine. It is listed on the Hong Kong Stock Exchange under the symbol XHKG.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations